U.S. Health Secretary Robert F. Kennedy Jr. has signed a new charter for the CDC's Advisory Committee on Immunization Practices (ACIP), broadening the panel's focus to include vaccine risks and alleged gaps in vaccine safety research. The charter, signed on March 31 and publicly posted shortly after, comes following a federal court ruling that challenged the legitimacy of Kennedy's previously reconstituted vaccine panel.
Last month, Boston-based U.S. District Judge Brian Murphy ruled that ACIP had been unlawfully restructured after Kennedy removed all 17 independent vaccine experts from the panel in 2024, replacing them with individuals who largely share his controversial stance on vaccine safety. The court placed the new panel's decisions on hold, prompting the latest charter revision.
The updated charter expands membership eligibility beyond traditional vaccine research and immunization expertise to now include specialists in toxicology, data science, and vaccine safety assessment. Critics argue the revised language — replacing stricter qualifications with the broader term "knowledgeable" — lowers the bar for panel membership and could make future legal challenges more difficult to sustain. Dorit Reiss, a vaccine policy law professor at UC Law San Francisco, raised this concern publicly.
The new charter also adds four non-voting liaison organizations, three of which — the Association of American Physicians and Surgeons, the Independent Medical Alliance, and Physicians for Informed Consent — have publicly expressed anti-vaccine positions. A fourth group, the Medical Academy of Pediatrics and Special Needs, advocates for children with autism, a condition Kennedy has repeatedly and falsely linked to childhood vaccines despite overwhelming scientific consensus to the contrary.
An HHS spokesperson described the charter renewal as routine and denied it signals any broader policy change. However, former CDC official Daniel Jernigan warned the move further politicizes vaccine guidance, while the American Academy of Pediatrics has not ruled out a legal challenge to the restructured panel.


Taiwan Scrambles Jets and Ships as China Intensifies Military Patrols Near Island
Trump Faces Pressure as Fed Chair Kevin Warsh Takes Over
Trump-Taiwan Call Could Reshape U.S.-China Relations, Says Taiwan Foreign Minister
Cambodia King Pardons Opposition Leader Kem Sokha After Treason Conviction
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
TrumpRx Expands Discount Drug Access With 600 Generic Medications
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Puerto Rico Economic Development Chief Resigns Amid Government Shake-Up
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
CDC Monitors 41 Americans After Andes Hantavirus Outbreak on Luxury Cruise Ship
DOJ May Drop Gautam Adani Fraud Charges Amid $10 Billion U.S. Investment Plan
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Zelenskiy Pushes Europe to Boost Missile Defense Production as U.S. Talks Stall
Iran Reopens International Internet Access After 87-Day Blackout
DOJ Sues UCLA Over Alleged Antisemitism and Hostile Campus Environment 



